Beth C. Seidenberg, Director at Vera Therapeutics, Inc. (VERA), bought 2,300 shares at $7.24 ($17K) on 2023-03-30, disclosed to the SEC on 2023-04-03.
Open-market purchase of $17k VERA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| VERA | SELL | 2024-09-20 | $1.3M | — | Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |